about
A cannabinoid 2 receptor agonist attenuates bone cancer-induced pain and bone lossPurinergic signalling and cancerFrom palliative therapy to prolongation of survival: (223)RaCl2 in the treatment of bone metastasesTreatment of Cancer Pain by Targeting CytokinesUse of Animal Models in Understanding Cancer-induced Bone PainAdvances in cancer pain from bone metastasisA lipid gate for the peripheral control of painEpigenetic regulation of persistent painNeuropathic cancer pain: What we are dealing with? How to manage it?The perception and endogenous modulation of painBehavioral, medical imaging and histopathological features of a new rat model of bone cancer painThe Walker 256 Breast Cancer Cell- Induced Bone Pain Model in RatsAttenuation of bone mass and increase of osteoclast formation in decoy receptor 3 transgenic mice.Tumor tissue-derived formaldehyde and acidic microenvironment synergistically induce bone cancer pain.Acid-Sensing Ion Channels and PainTargeting the Microglial Signaling Pathways: New Insights in the Modulation of Neuropathic Pain.Comparison of orofacial pain of patients with different stages of precancer and oral cancer.Regulation of acid signaling in rat pulmonary sensory neurons by protease-activated receptor-2.Serine proteases and protease-activated receptor 2-dependent allodynia: a novel cancer pain pathway.Optimization and In Vivo Profiling of a Refined Rat Model of Walker 256 Breast Cancer Cell-Induced Bone Pain Using Behavioral, Radiological, Histological, Immunohistochemical and Pharmacological MethodsThe Src family kinase inhibitor dasatinib delays pain-related behaviour and conserves bone in a rat model of cancer-induced bone pain.The application of genomic and molecular data in the treatment of chronic cancer pain.Adenosine triphosphate drives head and neck cancer pain through P2X2/3 heterotrimers.Hematopoietic colony-stimulating factors: new players in tumor-nerve interactions.Orofacial pain onset predicts transition to head and neck cancerSNPs in PTGS2 and LTA predict pain and quality of life in long term lung cancer survivors.Role of tissue stroma in cancer cell invasion.Divergence in endothelin-1- and bradykinin-activated store-operated calcium entry in afferent sensory neurons.Inhibition of p38-MAPK signaling pathway attenuates breast cancer induced bone pain and disease progression in a murine model of cancer-induced bone pain.Homing of cancer cells to the bone(18)F-FDG PET/CT and pain in metastatic bone cancer.Potential applications of siRNA for pain therapy.The effects of preoperative oral administration of carprofen or tramadol on postoperative analgesia in dogs undergoing cutaneous tumor removalCell signaling and the genesis of neuropathic pain.Targeting cells of the myeloid lineage attenuates pain and disease progression in a prostate model of bone cancerD-Amino acid oxidase-mediated increase in spinal hydrogen peroxide is mainly responsible for formalin-induced tonic pain.Nerve growth factor links oral cancer progression, pain, and cachexia.Re-expression of the methylated EDNRB gene in oral squamous cell carcinoma attenuates cancer-induced pain.Breakthrough pain in malignant and non-malignant diseases: a review of prevalence, characteristics and mechanisms.Emerging analgesics in cancer pain management.
P2860
Q24615787-788F1831-8A83-410A-B7D9-39C61750BF03Q24618782-8BF24AA1-FEFA-4642-A30E-156D0B0F18DAQ26740064-FB9D1C62-C2B3-41F0-A357-B8AFA09A96EEQ26779917-04AA6A42-8601-45DA-9404-6B737EE97867Q26785501-E660CE34-D396-4627-A66C-086D9BFA5FC9Q26796465-DD5F5BC2-60F0-4DEB-BD96-7B38E0CF3828Q26995053-BFA4B55A-71FD-4652-BF39-FE53575EED4EQ26998380-4C6F1E13-0CDA-49FF-8C01-6C1D5B286791Q26998945-B880E173-0CBE-4574-887D-D5973D8A1D97Q27011310-5D473BFD-6F63-4AFD-883D-D5FAAF6251EFQ27317157-D04A43A9-A0BA-48C7-B344-91662FB1C152Q28075980-21864534-E9FA-4511-B383-4437C65F96E3Q30827854-BB9DBB89-DA74-4C1F-AAE1-D5EE6DDC12FDQ33565555-58CD3787-2AA9-4125-8F72-FDB9C809D72BQ33664281-3FE20A98-542D-4E7F-883F-90CAF3C605FBQ33668659-5BE13DC3-41EB-4399-85C5-9E67EA4BBD97Q33671085-F76E8295-BF91-4A69-A7BC-99342B37C8C2Q33728194-423DB58B-AEE5-4100-8917-DF4FDDD165C6Q33818974-6E23280C-6D71-4588-A0EF-5C91F5404EA8Q33875227-00FBDAB5-4A58-44D9-A959-6933922EA2EBQ33881060-DD380EB6-538C-41F3-9FAA-D478A3679AB2Q34207230-F9DBF835-6E56-4100-B512-3446D5FF26C4Q34500229-EDEAD6BC-1BCD-426E-B2C6-2A96FD6C6384Q34663630-AC90F568-D040-44C1-B017-89C14167279FQ34997065-737DB3AE-EF8F-4317-B79A-79F3A281907AQ35038872-191DA372-142C-4273-A929-A92AA4948C59Q35170428-27A1D9D2-CF10-415A-85D0-AD4DE842AA59Q35418789-00013D22-4B8E-4B09-B1CA-5E0F5EC885FFQ35540734-665CE6A6-AA5A-46BE-BEA1-59B44D8E0099Q35603135-8407641D-A959-4F58-BE3E-169D477CD8F6Q35656608-D76BAEF9-5054-4148-988D-4763895B55DDQ35753527-CF10D463-6CBB-4D11-B399-CE9CE1F1F924Q35853312-38A0C332-161E-45D8-B98F-AE843E433508Q35904210-5D701D64-E37C-4B4E-AC11-6B6B489661F4Q35985440-AD68CC77-D19C-49DD-BAAF-C17CC3DE3183Q36025408-17648637-D2D7-41AE-BA20-76882117F1BBQ36031474-A74726DF-FD4A-4887-8903-F211781BABA5Q36031497-1DC28C96-DC24-47E7-B1D4-1D2B8C944263Q36057778-749CC0CB-4534-4212-8DCA-0D4E47CE15C9Q36066043-BFA6E078-EC8C-4A11-9A11-61A4A614BF19
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մարտին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Molecular mechanisms of cancer pain.
@ast
Molecular mechanisms of cancer pain.
@en
type
label
Molecular mechanisms of cancer pain.
@ast
Molecular mechanisms of cancer pain.
@en
prefLabel
Molecular mechanisms of cancer pain.
@ast
Molecular mechanisms of cancer pain.
@en
P2093
P356
P1476
Molecular mechanisms of cancer pain.
@en
P2093
Denis R Clohisy
Martin Koltzenburg
Patrick W Mantyh
Steve P Hunt
P2888
P304
P356
10.1038/NRC747
P407
P577
2002-03-01T00:00:00Z
P6179
1025501354